EMA is holding its regular fortnightly press briefing to provide updates on its COVID-19 activities on Thursday, 21 October at 1:30 pm.
The press briefing will be streamed via Europe by Satellite (live and video on demand). It will also be streamed live via EMA's YouTube channel. Footage from the press briefing can be used for free, in accordance with the copyright here.
Video stock footage of the EMA building is available here and photos of EMA here. Please note that the press briefing will be held in English. No translations will be provided.
Journalists who would like to actively participate at the press briefing need to be first accredited by the EMA. They can submit their request to be accredited via email to [email protected] attaching a copy of their press pass or a letter from the editor confirming their affiliation. Once accredited they will receive invitations to all future EMA press briefings.
Lisätietoja:
European Medicines Agency
[email protected], p. +31 (0)88 781 8427
Lääkealan turvallisuus- ja kehittämiskeskus Fimea valvoo ja kehittää lääkealaa sekä edistää lääkkeiden järkevää käyttöä väestön terveydeksi.
© Koodiviidakko Oy - Y-tunnus 1939962-1